Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To compare progression-free survival (PFS) in subjects with pancreatic islet cell tumors treated with sunitinib (at a starting dose of 37.5 mg daily continuous dosing) with those treated with placebo
Inclusion criteria
- Progressive, advanced/metastatic well-differentiated pancreatic islet cell tumours